PPT-Dabigatran in myocardial injury after noncardiac

Author : lois-ondreau | Published Date : 2018-09-22

surgery Dr PJ Devereaux on behalf of MANAGE Investigators Population Health Research Institute Hamilton Canada Background MINS includes MI and isolated ischemic

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Dabigatran in myocardial injury after n..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Dabigatran in myocardial injury after noncardiac: Transcript


surgery Dr PJ Devereaux on behalf of MANAGE Investigators Population Health Research Institute Hamilton Canada Background MINS includes MI and isolated ischemic troponin elevation that occur within first 30 days after surgery . 11 Cardiac Markers 13 after myocardial injury than any other marker available so far.early as 2 to 3 hours after the onset. Its peak value is obtainednormalizes over the next 24 hours. However, it i FAINELLI . Manon. BOGÓ . Ákos. . Szakács . Júlia . M.D. . . Department of Pathophysiology. Numbers…. Cardiovascular diseases . The most frequent cause of death. 7.5 millions of death/ year. Important concerns in developed countries. Eliot Williams, MD PhD. Division of Hematology & Medical Oncology. History of anticoagulant therapy. 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010. VIABILITY. CORONARY ARTERY DISEASE. ACUTE CORONARY SYNDROME. Undergo . revascularisation. procedures. . Improved survival. Increased number of patients with residual LV dysfunction undergoing progressive LV remodeling and congestive heart failure. Babak Moini, MD. Veterans Affairs Hospital. Noon Lecture . S. eries. Acknowledgment: . Some of the slides were borrowed from Amanda Miller Phar.D. . Case1. 68 male with . hx. of DM, CHF and prior ischemic CVA admitted for new . CDI Implications. ACDIS Radio – August 29, 2018. James S. Kennedy, MD, CCS, CDIP. President and Chief Medical Officer. CDIMD – Physician Champions. Smyrna, Tennessee. jkennedy@cdimd.com. – (615) 479-7021. Lec. 3 Part 1. 3. rd. Grade – Fall Semester 2021-2022. . Goran N. Saleh . goran.nori. @tiu.edu.iq. 22/11/2021. BIOMARKER. “A . biomarker . is a substance . used . as. . an . indicator . of . a biologic. Jill O’Brien, MD. Medical Director Case Management. Physician Advisor to CDI/Coding. The Miriam Hospital. Clarifying Principles. Clear Definition for Type 2 . MI. Expanded Rationale for Elevated . T. Definition. Acute coronary syndrome (ACS) is a term used to describe a constellation of symptoms resulting from acute myocardial ischemia. ACS includes the diagnosis of unstable angina (UA), non-ST elevation myocardial infarction. 1  fracture in two or more places  Serious chest wall injury with underlying pulmonary injury – Reduces volume of ventilation  Paradoxical movement Pathophysiology of Thoracic Trauma Flai Summary of webinar by released by Washington University and Barnes Jewish Hospitals . https://vimeo.com/440814898. Benefits of high sensitivity troponin . Measures the same cardiac specific troponin molecule as conventional assay, but can detect at levels 10 fold lower (better sensitivity). NOAC vs Warfarin Atrial Fibrillation Studies – Asian representation. RE-LY. ROCKET. ARISTOTLE. ENGAGE. Drug. Dabigatran. Rivaroxaban. Apixaban. Edoxaban. Class. DTI. Anti-. Xa. Anti-. Xa. Anti-. Xa. . 2024 AHA/ACC/ACS/ASNC/. HRS/SCA/SCCT/SCMR/SVM . Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. AHA Clinical Update PPTX. Table 1. . Applying Class of Recommendation and Level of Evidence to Clinical Strategies,... Dr. PJ Devereaux on behalf of POISE-3. Investigators. Population Health Research Institute, Hamilton, Canada. Funding: Canadian Institutes of Health Research, . National Health and Medical Research Council (Australia), Research Grant Council (Hong...

Download Document

Here is the link to download the presentation.
"Dabigatran in myocardial injury after noncardiac"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents